← Back to directory

Lorraine O’Driscoll

Researcher Next ID · RN-027504

Researcher · Biochemistry, Genetics and Molecular Biology

Trinity College Dublin

Dublin, Ireland

Not currently recruitingFunding unknown
Works count
225
Citation count
38,964
H-index
59
i10-index
123

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Extracellular vesicles in disease
MicroRNA in disease regulation
HER2/EGFR in Cancer Research
Cancer Cells and Metastasis
Cell Adhesion Molecules Research

Publications

  • Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles · 2024 · https://doi.org/10.1002/jev2.12404

  • Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles

    Journal of Extracellular Vesicles · 2021 · 10.1002/jev2.12182

  • Mesenchymal Stem Cell Derived Extracellular Vesicles for Tissue Engineering and Regenerative Medicine Applications

    Cells · 2020 · 10.3390/cells9040991

  • Inhibiting extracellular vesicles formation and release: a review of EV inhibitors

    Journal of Extracellular Vesicles · 2019 · 10.1080/20013078.2019.1703244

  • Extracellular vesicles and anti-cancer drug resistance

    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2018 · 10.1016/j.bbcan.2018.07.003

  • Extracellular vesicles and anti-cancer drug resistance

    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2018 · 10.1016/j.bbcan.2018.07.003

  • EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

    Nature Methods · 2017 · https://doi.org/10.1038/nmeth.4185

  • Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

    ACS Nano · 2016 · 10.1021/acsnano.5b08015

  • The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance

    Oncotarget · 2016 · 10.18632/oncotarget.9935

  • miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

    Oncotarget · 2015 · 10.18632/oncotarget.5192

  • miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

    Oncotarget · 2015 · 10.18632/oncotarget.5192

  • Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

    Journal of Extracellular Vesicles · 2015 · https://doi.org/10.3402/jev.v4.30087

  • Biological properties of extracellular vesicles and their physiological functions

    Journal of Extracellular Vesicles · 2015 · https://doi.org/10.3402/jev.v4.27066

  • miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

    The Prostate · 2014 · 10.1002/pros.22848

  • miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

    The Prostate · 2014 · 10.1002/pros.22848

  • Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies

    Obesity Reviews · 2014 · https://doi.org/10.1111/obr.12229

  • Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

    European Journal of Cancer · 2013 · 10.1016/j.ejca.2013.01.017

  • Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

    European Journal of Cancer · 2013 · 10.1016/j.ejca.2013.01.017

  • Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis

    Carcinogenesis · 2013 · 10.1093/carcin/bgt208

  • Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

    PLoS ONE · 2012 · 10.1371/journal.pone.0050999

  • Three-dimensional cell culture: the missing link in drug discovery

    Drug Discovery Today · 2012 · 10.1016/j.drudis.2012.10.003

  • Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

    Molecular Cancer · 2011 · 10.1186/1476-4598-10-126

  • Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

    Molecular Cancer · 2011 · 10.1186/1476-4598-10-126

  • Intracellular and Extracellular MicroRNAs in Breast Cancer

    Clinical Chemistry · 2010 · 10.1373/clinchem.2010.150730

  • Intracellular and Extracellular MicroRNAs in Breast Cancer

    Clinical Chemistry · 2010 · 10.1373/clinchem.2010.150730

  • Prognostic importance of survivin in breast cancer

    British Journal of Cancer · 2003 · https://doi.org/10.1038/sj.bjc.6600776

  • Matrix Metalloproteinase Expression and Production by Alveolar Macrophages in Emphysema

    American Journal of Respiratory and Critical Care Medicine · 1997 · 10.1164/ajrccm.156.1.9612018

Current projects

    No projects listed.